92 related articles for article (PubMed ID: 24813390)
1. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
Nasr M; Nafee N; Saad H; Kazem A
Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
[TBL] [Abstract][Full Text] [Related]
2. Poly(lactic-
Kumar P; Singh AK; Raj V; Rai A; Keshari AK; Kumar D; Maity B; Prakash A; Maiti S; Saha S
Int J Nanomedicine; 2018; 13():975-990. PubMed ID: 29497292
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats.
Chu TH; Chan HH; Hu TH; Wang EM; Ma YL; Huang SC; Wu JC; Chang YC; Weng WT; Wen ZH; Wu DC; Chen YA; Tai MH
Cancer Med; 2018 Jun; 7(6):2567-2580. PubMed ID: 29683262
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy.
Huang C; Li NM; Gao P; Yang S; Ning Q; Huang W; Li ZP; Ye PJ; Xiang L; He DX; Tan XW; Yu CY
Drug Deliv; 2017 Nov; 24(1):459-466. PubMed ID: 28219253
[TBL] [Abstract][Full Text] [Related]
5. 3-Indolepropionic acid mitigates sub-acute toxicity in the cardiomyocytes of epirubicin-treated female rats.
Owumi S; Arunsi U; Otunla M; Adebisi G; Altayyar A; Irozuru C
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):507-520. PubMed ID: 37477660
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in rats.
Golla K; Cherukuvada B; Ahmed F; Kondapi AK
PLoS One; 2012; 7(12):e51960. PubMed ID: 23284832
[TBL] [Abstract][Full Text] [Related]
7. Targeted Manganese doped silica nano GSH-cleaner for treatment of Liver Cancer by destroying the intracellular redox homeostasis.
Tang H; Li C; Zhang Y; Zheng H; Cheng Y; Zhu J; Chen X; Zhu Z; Piao JG; Li F
Theranostics; 2020; 10(21):9865-9887. PubMed ID: 32863964
[No Abstract] [Full Text] [Related]
8. Reduction-sensitive polymeric carrier for the targeted delivery of a quinazoline derivative for enhanced generation of reactive oxygen species against cancer.
Cao J; Hong K; Lv C; Jiang W; Chen Q; Wang R; Wang Y
Biomater Sci; 2024 May; 12(10):2626-2638. PubMed ID: 38526801
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in hepatocellular carcinoma-targeted nanoparticles.
Liu X; Bai Y; Zhou B; Yao W; Song S; Liu J; Zheng C
Biomed Mater; 2024 May; 19(4):. PubMed ID: 38697209
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity and targeting p53-PUMA mRNA expression by 5-flurouracil PLGA-lipid polymeric nanoparticles in mouse mammary carcinomas: comparison to free 5-flurouracil.
Alsharif ST; Gardouh AM; Mandour MF; Alaqais ZM; Alharbi LK; Almarwani MJ; Mokhtar HI; Hisham FA; Abdellah MM; Mohamed GM; Shorog EM; Almaeen AH; Atteia HH; Zaitone SA
Toxicol Mech Methods; 2024 May; 34(4):385-397. PubMed ID: 38083807
[TBL] [Abstract][Full Text] [Related]
11. Development of chitosan-folate modified PLGA nanoparticles for targeted delivery of diosgenin as an anticancer agent.
Teymouri F; Karimi E
Discov Oncol; 2024 Apr; 15(1):100. PubMed ID: 38568336
[TBL] [Abstract][Full Text] [Related]
12. Engineered cell membrane-coated nanoparticles based cancer therapy: A robust weapon against the lethal and challenging hepatocellular carcinoma.
Zhang J; Yu H; Li G
Biointerphases; 2024 Mar; 19(2):. PubMed ID: 38607255
[TBL] [Abstract][Full Text] [Related]
13. Iron(III)-Tannic Molecular Nanoparticles Enhance Autophagy effect and T
Saowalak K; Titipun T; Somchai T; Chalermchai P
Sci Rep; 2018 Apr; 8(1):6647. PubMed ID: 29703912
[TBL] [Abstract][Full Text] [Related]
14. Chitosan and
Radwan AM; Gebreel DT; Allam S; El-Atrash A; Tousson E
Toxicol Res (Camb); 2024 Apr; 13(2):tfae050. PubMed ID: 38559757
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial-Targeted CS@KET/P780 Nanoplatform for Site-Specific Delivery and High-Efficiency Cancer Immunotherapy in Hepatocellular Carcinoma.
Liu S; Tian H; Ming H; Zhang T; Gao Y; Liu R; Chen L; Yang C; Nice EC; Huang C; Bao J; Gao W; Shi Z
Adv Sci (Weinh); 2024 Apr; 11(14):e2308027. PubMed ID: 38308137
[TBL] [Abstract][Full Text] [Related]
16. Nanostructures Control the Hepatocellular Responses to a Cytotoxic Agent "Cisplatin".
Abdellatef SA; Tange R; Sato T; Ohi A; Nabatame T; Taniguchi A
Biomed Res Int; 2015; 2015():925319. PubMed ID: 26247032
[TBL] [Abstract][Full Text] [Related]
17. Tocotrienols as an Anti-Breast Cancer Agent.
Trujillo M; Kharbanda A; Corley C; Simmons P; Allen AR
Antioxidants (Basel); 2021 Aug; 10(9):. PubMed ID: 34573015
[TBL] [Abstract][Full Text] [Related]
18. δ-tocotrienol induces human bladder cancer cell growth arrest, apoptosis and chemosensitization through inhibition of STAT3 pathway.
Ye C; Zhao W; Li M; Zhuang J; Yan X; Lu Q; Chang C; Huang X; Zhou J; Xie B; Zhang Z; Yao X; Yan J; Guo H
PLoS One; 2015; 10(4):e0122712. PubMed ID: 25849286
[TBL] [Abstract][Full Text] [Related]
19. The use of delta-tocotrienol and lovastatin for anti-osteoporotic therapy.
Abdul-Majeed S; Mohamed N; Soelaiman IN
Life Sci; 2015 Mar; 125():42-8. PubMed ID: 25534439
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity and apoptotic activities of alpha-, gamma- and delta-tocotrienol isomers on human cancer cells.
Lim SW; Loh HS; Ting KN; Bradshaw TD; Zeenathul NA
BMC Complement Altern Med; 2014 Dec; 14():469. PubMed ID: 25480449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
